-
Regulatory & ComplianceNovo’s Monlunabant Shows Side Effects in Phase 2 Trial
4 min read • 2 years ago -
-
Discovery & DevelopmentLexaria’s GLP-1 Study Shows Promising 8-Week Weight Loss Results
4 min read • 2 years ago -
Funding & InvestmentsScorpius Holdings Reports 16% Revenue Growth in Q2 2024
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves First Nasal Spray for Allergic Reactions
4 min read • 2 years ago -
Discovery & DevelopmentViking Therapeutics Advances Obesity Drug to Phase 3 with $300M Clinical Program
4 min read • 2 years ago -
-
-
-
Unlocking the Future of Biotechnology.
Access unparalleled market intelligence, R&D clinical trial tracking, and editorial authority from the industry's most trusted navigators.
TRUSTED BY 20,000+ INDUSTRY ANALYSTS
Log in
Enter your credentials to continue.
